https://map4k-receptor.com/ind....ex.php/identificatio
Customers had been arbitrarily assigned (11) to receive either WBRT (20 Gy in five fractions) or SRS (15 Gy in one single fraction). The principal end point ended up being the rate of accrual each month. Secondary feasibility and medical end points included the ratio of accrued subjects to screened subjects. This test is registered with ClinicalTrials.gov (number NCT02220491). Causes complete, 210 customers were screened to enrol 22 patients in to the trial; 20 clients had been randomised between the tw
إعجاب
علق
شارك
